1. Statutory Text and Role in the Pharmaceutical Offence Triad
While Section 276 BNS targets the upstream manufacturer or compounder who adulterates a drug, Section 277 of the Bharatiya Nyaya Sanhita, 2023 (BNS) targets the downstream seller, pharmacist, dispensary keeper, or administrator who places an already adulterated drug into circulation or medical use S1, ss. 276, 277. The enacted Gazette text states verbatim:
277. Sale of adulterated drugs.—Whoever, knowing any drug or medical preparation to have been adulterated in such a manner as to lessen its efficacy, to change its operation, or to render it noxious, sells the same, or offers or exposes it for sale, or issues it from any dispensary for medicinal purposes as unadulterated, or causes it to be used for medicinal purposes by any person not knowing of the adulteration, shall be punished with imprisonment of either description for a term which may extend to six months, or with fine which may extend to five thousand rupees, or with both. S1, s. 277
Section 277 BNS is deliberately structured to close every commercial and clinical channel through which an adulterated medicine might reach a patient: retail sale, shelf display ("exposes it for sale"), free hospital or charitable dispensary distribution ("issues it from any dispensary for medicinal purposes"), and direct administration or prescription ("causes it to be used for medicinal purposes by any person not knowing of the adulteration") S1, s. 277.
2. Exact Offence Ingredients and the Strict "Knowing" Mental Standard
To convict an accused under Section 277 BNS, the prosecution must establish three cumulative ingredients S1, s. 277:
- Pre-existing Qualifying Adulteration (Actus Reus: Attendant Circumstance):
- The subject matter must be a drug or medical preparation that has in fact been adulterated in such a manner as to:
- (a) lessen its efficacy,
- (b) change its operation, or
- (c) render it noxious S1, s. 277.
- As emphasized by the Supreme Court in Medipol Pharmaceutical India Pvt. Ltd. v. PGIMER, (2021) 11 SCC 339, establishing that a pharmaceutical preparation has lost efficacy or been adulterated ordinarily requires reliable chemical analysis or laboratory testing demonstrating deviation from the standard composition or potency S7, paras 12–18.
- The subject matter must be a drug or medical preparation that has in fact been adulterated in such a manner as to:
- Actual Knowledge of the Adulteration (Mens Rea):
- The statute opens with the words: "Whoever, knowing any drug or medical preparation to have been adulterated..." S1, s. 277.
- Critical Contrast with Section 275 BNS (Noxious Food): Under Section 275 BNS (sale of noxious food or drink), Parliament used the broader mental standard "knowing or having reason to believe" (defined in Section 2(29) BNS as having sufficient cause to believe) S1, ss. 2(29), 275. By contrast, in Section 277 BNS, the legislature omitted "having reason to believe" and required actual knowledge ("knowing") that the drug has been adulterated so as to lessen its efficacy, change its operation, or render it noxious S1, s. 277.
- Consequently, mere negligence by a retail chemist in failing to test a sealed manufacturer's strip, without actual knowledge of the adulteration, does not satisfy the mens rea of Section 277 BNS (though regulatory liability under the Drugs and Cosmetics Act, 1940 may separately arise if statutory warranty conditions under Section 19(3) of that Act are not met) S1, s. 277; S6.
- Distribution or Use as Unadulterated (Actus Reus: Conduct):
- Possessing such knowledge, the accused must perform at least one of four specified acts S1, s. 277:
- (i) Sells the same;
- (ii) Offers or exposes it for sale (e.g., displaying it on a pharmacy counter or online medicine catalog for purchase);
- (iii) Issues it from any dispensary (whether a paid pharmacy, government hospital dispensary, or charitable clinic) for medicinal purposes as unadulterated; or
- (iv) Causes it to be used for medicinal purposes by any person not knowing of the adulteration (e.g., a nursing home proprietor or ward attendant giving the adulterated medicine to an unsuspecting patient or nurse) S1, s. 277.
- Note how the fourth limb ("by any person not knowing of the adulteration") and third limb ("as unadulterated") reinforce that deception as to the drug's integrity is central to the offence S1, s. 277.
- Possessing such knowledge, the accused must perform at least one of four specified acts S1, s. 277:
3. IPC-to-BNS Correspondence and Statutory Comparison
Section 277 BNS corresponds directly to Section 275 of the Indian Penal Code, 1860 (IPC) S4, s. 275; S5:
| Attribute | IPC Section 275 (Repealed w.e.f. 01-07-2024) | BNS Section 277 (Effective 01-07-2024) | Legal & Practical Significance |
|---|---|---|---|
| Section Number & Heading | Section 275: Sale of adulterated drugs. S4, s. 275 | Section 277: Sale of adulterated drugs. S1, s. 277 | Renumbered in Chapter XV of the BNS S5. |
| Substantive Ingredients | Knowing adulteration (lessening efficacy, changing operation, or rendering noxious) + selling, offering/exposing for sale, issuing from dispensary as unadulterated, or causing use by unknowing person S4, s. 275 | Identical verbatim wording S1, s. 277 | Complete continuity of offence ingredients and mens rea ("knowing") S1, s. 277; S4, s. 275. |
| Maximum Imprisonment | Imprisonment of either description up to six months S4, s. 275 | Imprisonment of either description up to six months S1, s. 277 | Unchanged. Note that while Section 276 BNS doubled imprisonment for adulterating drugs to 1 year, Section 277 BNS retained 6 months for selling them S1, ss. 276, 277. |
| Maximum Fine | Up to ₹1,000 ("one thousand rupees") S4, s. 275 | Up to ₹5,000 ("five thousand rupees") S1, s. 277 | Five-fold increase in maximum fine ceiling S1, s. 277; S4, s. 275. |
| Default-of-Fine Imprisonment | Up to 1.5 months (one-fourth of 6 months under Section 65 IPC) S4, s. 65 | Up to 1.5 months (one-fourth of 6 months under Section 8(3) BNS) S1, s. 8(3) | Unchanged because maximum imprisonment remains 6 months S1, s. 8(3). |
4. Punishment Matrix and Sentencing Rules
- Imprisonment: Up to six months of either description (rigorous, simple, or a combination thereof under Section 7 BNS), with no mandatory minimum term S1, ss. 7, 277.
- Fine: Discretionary ("or with fine... or with both"), capped at ₹5,000 S1, s. 277.
- Default of Payment of Fine: Under Section 8(3) BNS, imprisonment in default of payment of fine cannot exceed one-fourth of six months (i.e., one month and fifteen days), and may be rigorous or simple per Section 8(4) BNS S1, s. 8(3)–(4).
5. Procedural Classification (BNSS 2023) and Special-Law Interaction
Under the First Schedule to the BNSS, 2023, Section 277 BNS is classified as S2, First Schedule:
- Non-cognizable: Police cannot arrest without warrant or investigate without a Magistrate's order under Section 174(2) BNSS S2, s. 174, First Schedule.
- Bailable: Bail is a matter of right S2, First Schedule.
- Triable by Any Magistrate, and expressly triable summarily by a Chief Judicial Magistrate or Judicial Magistrate of the first class under Section 283(1)(i) BNSS S2, s. 283(1)(i), First Schedule.
- Non-compoundable under Section 359 BNSS S2, s. 359.
Overlap with the Drugs and Cosmetics Act, 1940: Selling, stocking, or exhibiting for sale any adulterated or spurious drug is also a serious offence under Section 18(a)(i) read with Section 27 of the Drugs and Cosmetics Act, 1940 S6. Under Section 1(6) BNS and Section 5 BNSS, the special law prevails within its sphere, and per Union of India v. Ashok Kumar Sharma, (2021) 12 SCC 674, prosecutions under Chapter IV of the 1940 Act must be instituted by a Drugs Inspector or statutorily authorized complainant under Section 32 of that Act S1, s. 1(6); S2, s. 5; S6, paras 150–170. Where the same act constitutes an offence under both enactments, Section 26 of the General Clauses Act, 1897 bars punishing the offender twice for the same offence.
6. Temporal Applicability
Section 277 BNS took effect on 1 July 2024 S3. Under Section 358(2) BNS and Article 20(1) of the Constitution, any sale, exposure for sale, or dispensary issue of an adulterated drug occurring prior to 1 July 2024 is governed by Section 275 IPC (where the fine cannot exceed ₹1,000), whereas conduct on or after 1 July 2024 is governed by Section 277 BNS (where the fine may extend to ₹5,000) S1, ss. 277, 358(2); S4, s. 275.
7. Practical Illustrations and Counterexamples
- Editorial Hypothetical 1 (Free Charitable Dispensary Issue: Offence Committed): D, the storekeeper of a charitable clinic where medicines are distributed free of charge, learns from a supplier's recall notice that a batch of antimalarial syrup has been chemically adulterated, reducing its active ingredient by 70%. Instead of discarding the stock, D issues the bottles from the clinic dispensary to patients without disclosing the adulteration. Even though D made no commercial "sale," he issued the drug "from any dispensary for medicinal purposes as unadulterated" with actual knowledge of the adulteration, attracting Section 277 BNS S1, s. 277.
- Editorial Hypothetical 2 (Causing Use by Unknowing Nurse: Offence Committed): E, a clinic administrator who knows that sterile saline vials have been contaminated with non-sterile tap water (rendering them noxious), places them on the injection tray of Nurse N without telling N, who then administers the drip to a patient. E has caused the adulterated preparation to be used for medicinal purposes by a person (N and the patient) not knowing of the adulteration, and is liable under Section 277 BNS S1, s. 277.
- Editorial Counterexample (Retail Chemist Without Knowledge: No Offence Under Section 277 BNS): F, a licensed retail pharmacist, purchases sealed blister packs of paracetamol from a licensed wholesale distributor accompanied by a written warranty, and displays them for sale. Unknown to F, the manufacturer had adulterated the batch with chalk. Because F lacked actual knowledge ("knowing") that the drug had been adulterated, F cannot be convicted under Section 277 BNS S1, s. 277.